India · Delayed Price · Currency is INR Poly Medicure Statistics
Total Valuation
Poly Medicure has a market cap or net worth of INR 167.84 billion. The enterprise value is 164.21 billion.
| Market Cap | 167.84B |
| Enterprise Value | 164.21B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Aug 28, 2026 |
Share Statistics
| Current Share Class | 101.36M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.19% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 36.98% |
| Owned by Institutions (%) | 21.53% |
| Float | 36.34M |
Valuation Ratios
The trailing PE ratio is 52.76 and the forward PE ratio is 36.62.
| PE Ratio | 52.76 |
| Forward PE | 36.62 |
| PS Ratio | 7.68 |
| PB Ratio | 4.96 |
| P/TBV Ratio | 5.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 62.10 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 50.34 |
| EV / Sales | 7.51 |
| EV / EBITDA | 32.56 |
| EV / EBIT | 45.19 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.12.
| Current Ratio | 3.13 |
| Quick Ratio | 2.12 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | n/a |
| Interest Coverage | 13.28 |
Financial Efficiency
Return on equity (ROE) is 10.14% and return on invested capital (ROIC) is 9.28%.
| Return on Equity (ROE) | 10.14% |
| Return on Assets (ROA) | 5.62% |
| Return on Invested Capital (ROIC) | 9.28% |
| Return on Capital Employed (ROCE) | 9.93% |
| Weighted Average Cost of Capital (WACC) | 4.86% |
| Revenue Per Employee | 8.16M |
| Profits Per Employee | 1.22M |
| Employee Count | 2,614 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.52 |
Taxes
In the past 12 months, Poly Medicure has paid 1.09 billion in taxes.
| Income Tax | 1.09B |
| Effective Tax Rate | 25.69% |
Stock Price Statistics
The stock price has decreased by -10.51% in the last 52 weeks. The beta is 0.11, so Poly Medicure's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -10.51% |
| 50-Day Moving Average | 1,627.46 |
| 200-Day Moving Average | 1,544.36 |
| Relative Strength Index (RSI) | 63.95 |
| Average Volume (20 Days) | 85,374 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Poly Medicure had revenue of INR 21.34 billion and earned 3.18 billion in profits. Earnings per share was 31.37.
| Revenue | 21.34B |
| Gross Profit | 14.81B |
| Operating Income | 3.48B |
| Pretax Income | 4.26B |
| Net Income | 3.18B |
| EBITDA | 4.82B |
| EBIT | 3.48B |
| Earnings Per Share (EPS) | 31.37 |
Balance Sheet
The company has 8.18 billion in cash and 4.12 billion in debt, with a net cash position of 4.06 billion.
| Cash & Cash Equivalents | 8.18B |
| Total Debt | 4.12B |
| Net Cash | 4.06B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 33.08B |
| Book Value Per Share | 321.97 |
| Working Capital | 13.84B |
Cash Flow
In the last 12 months, operating cash flow was 2.64 billion and capital expenditures -2.75 billion, giving a free cash flow of -114.07 million.
| Operating Cash Flow | 2.64B |
| Capital Expenditures | -2.75B |
| Depreciation & Amortization | 1.34B |
| Net Borrowing | 455.46M |
| Free Cash Flow | -114.07M |
| FCF Per Share | n/a |
Margins
Gross margin is 69.38%, with operating and profit margins of 16.32% and 14.92%.
| Gross Margin | 69.38% |
| Operating Margin | 16.32% |
| Pretax Margin | 19.94% |
| Profit Margin | 14.92% |
| EBITDA Margin | 22.59% |
| EBIT Margin | 16.32% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 0.21%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 0.21% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 21.27% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.19% |
| Shareholder Yield | 0.41% |
| Earnings Yield | 1.90% |
| FCF Yield | -0.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Poly Medicure is 1,836.00, which is 10.94% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,836.00 |
| Price Target Difference | 10.94% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 19.43% |
| EPS Growth Forecast (3Y) | 24.86% |
Stock Splits
The last stock split was on March 24, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Mar 24, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |